Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

CD155 on human vascular endothelial cells attenuates the acquisition of effector functions in CD8 T cells.

Escalante NK, von Rossum A, Lee M, Choy JC.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1177-84. doi: 10.1161/ATVBAHA.111.224162. Epub 2011 Feb 17.

PMID:
21330602
[PubMed - indexed for MEDLINE]
Free Article
2.

IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.

Schneider R, Yaneva T, Beauseigle D, El-Khoury L, Arbour N.

Eur J Immunol. 2011 Jan;41(1):47-59. doi: 10.1002/eji.201040804. Epub 2010 Dec 9.

PMID:
21182076
[PubMed - indexed for MEDLINE]
3.

IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.

Ortega C, Fernández-A S, Carrillo JM, Romero P, Molina IJ, Moreno JC, Santamaría M.

J Leukoc Biol. 2009 Aug;86(2):435-43. doi: 10.1189/JLB.0109046.

PMID:
19487306
[PubMed - indexed for MEDLINE]
Free Article
4.

Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.

Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.

Hum Immunol. 2004 Feb;65(2):142-56.

PMID:
14969769
[PubMed - indexed for MEDLINE]
5.

CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.

Kinter AL, Horak R, Sion M, Riggin L, McNally J, Lin Y, Jackson R, O'shea A, Roby G, Kovacs C, Connors M, Migueles SA, Fauci AS.

AIDS Res Hum Retroviruses. 2007 Mar;23(3):438-50.

PMID:
17411377
[PubMed - indexed for MEDLINE]
6.

Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor.

Morel Y, Schiano de Colella JM, Harrop J, Deen KC, Holmes SD, Wattam TA, Khandekar SS, Truneh A, Sweet RW, Gastaut JA, Olive D, Costello RT.

J Immunol. 2000 Oct 15;165(8):4397-404.

PMID:
11035077
[PubMed - indexed for MEDLINE]
Free Article
7.

Reverse signalling of membrane-integrated tumour necrosis factor differentially regulates alloresponses of CD4+ and CD8+ T cells against human microvascular endothelial cells.

Vudattu NK, Holler E, Ewing P, Schulz U, Haffner S, Burger V, Kirchner S, Andreesen R, Eissner G.

Immunology. 2005 Aug;115(4):536-43.

PMID:
16011522
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Testicular Sertoli cells influence the proliferation and immunogenicity of co-cultured endothelial cells.

Fan P, He L, Pu D, Lv X, Zhou W, Sun Y, Hu N.

Biochem Biophys Res Commun. 2011 Jan 21;404(3):829-33. doi: 10.1016/j.bbrc.2010.12.068. Epub 2010 Dec 21.

PMID:
21172306
[PubMed - indexed for MEDLINE]
9.

Human regulatory CD8 T cells.

Ablamunits V, Bisikirska BC, Herold KC.

Ann N Y Acad Sci. 2008 Dec;1150:234-8. doi: 10.1196/annals.1447.000.

PMID:
19120302
[PubMed - indexed for MEDLINE]
10.

Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation.

Câmara NO, Sebille F, Lechler RI.

Eur J Immunol. 2003 Dec;33(12):3473-83.

PMID:
14635058
[PubMed - indexed for MEDLINE]
11.

ADAM 15 is an adhesion receptor for platelet GPIIb-IIIa and induces platelet activation.

Langer H, May AE, Bültmann A, Gawaz M.

Thromb Haemost. 2005 Sep;94(3):555-61.

PMID:
16268472
[PubMed - indexed for MEDLINE]
12.

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.

Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.

Blood. 2004 Oct 15;104(8):2418-24. Epub 2004 Jun 17.

PMID:
15205263
[PubMed - indexed for MEDLINE]
Free Article
13.

Functional heterogeneity of cytokines and cytolytic effector molecules in human CD8+ T lymphocytes.

Sandberg JK, Fast NM, Nixon DF.

J Immunol. 2001 Jul 1;167(1):181-7.

PMID:
11418647
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro.

Klingenberg R, Autschbach F, Gleissner C, Giese T, Wambsganss N, Sommer N, Richter G, Katus HA, Dengler TJ.

Eur J Immunol. 2005 Jun;35(6):1712-21.

PMID:
15864782
[PubMed - indexed for MEDLINE]
16.

alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.

Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.

Hum Immunol. 2007 May;68(5):334-41. Epub 2007 Feb 21.

PMID:
17462500
[PubMed - indexed for MEDLINE]
17.

IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype.

Casey KA, Mescher MF.

J Immunol. 2007 Jun 15;178(12):7640-8.

PMID:
17548600
[PubMed - indexed for MEDLINE]
Free Article
18.

Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells.

Kish DD, Volokh N, Baldwin WM 3rd, Fairchild RL.

J Immunol. 2011 Feb 15;186(4):2117-26. doi: 10.4049/jimmunol.1002337. Epub 2011 Jan 14.

PMID:
21239709
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells.

Schildberg FA, Hegenbarth SI, Schumak B, Scholz K, Limmer A, Knolle PA.

Eur J Immunol. 2008 Apr;38(4):957-67. doi: 10.1002/eji.200738060. Erratum in: Eur J Immunol. 2008 Jun;38(6):1767. Scholz, Kai [added].

PMID:
18383043
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk